Fourth FDA Drug Chief This Year Steps Down, Raising Stability Concerns

The FDA White Oak Campus, headquarters of the U.S. Food and Drug Administration

Key Takeaways

  • Dr. Richard Pazdur will retire after 26 years at the FDA

  • He was the fourth person to lead the Center for Drug Evaluation and Research (CDER)

  • Experts warn that ongoing departures could weaken confidence in the FDA’s drug-approval process

Originally published on healthday.com, part of the BLOX Digital Content Exchange.